Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. (Q53167532)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. |
scientific article |
Statements
Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. (English)
1 reference
A J Colquhoun
1 reference
N A Venier
1 reference
A D Vandersluis
1 reference
R Besla
1 reference
L M Sugar
1 reference
A Kiss
1 reference
N E Fleshner
1 reference
M Pollak
1 reference
L H Klotz
1 reference
V Venkateswaran
1 reference
22 May 2012
1 reference
15
1 reference
4
1 reference
346-352
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference